• Je něco špatně v tomto záznamu ?

SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation

O. Durydivka, M. Kuchar, J. Blahos

. 2025 ; 10 (2) : 247-257. [pub] 20240709

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009404

Background: Activation of cannabinoid receptor 1 (CB1R) in the nervous system modulates the processing of acute and chronic pain. CB1R activity is regulated by desensitization and internalization. SH3-containing GRB2-like protein 3-interacting protein 1 (SGIP1) inhibits the internalization of CB1R. This causes increased and prolonged association of the desensitized receptor with G protein-coupled receptor kinase 3 (GRK3) and beta-arrestin on the cell membrane and results in decreased activation of extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. Genetic deletion of SGIP1 in mice leads to altered CB1R-related functions, such as decreased anxiety-like behaviors, modified cannabinoid tetrad behaviors, reduced acute nociception, and increased sensitivity to analgesics. In this work, we asked if deletion of SGIP1 affects chronic nociception and analgesic effect of Δ9-tetrahydrocannabinol (THC) and WIN 55,212-2 (WIN) in mice. Methods: We measured tactile responses of hind paws to increasing pressure in wild-type and SGIP1 knock-out mice. Inflammation in the paw was induced by local injection of carrageenan. To determine the mechanical sensitivity, the paw withdrawal threshold (PWT) was measured using an electronic von Frey instrument with the progression of the applied force. Results: The responses to mechanical stimuli varied depending on the sex, genotype, and treatment. SGIP1 knock-out male mice exhibited lower PWT than wild-type males. On the contrary, the female mice exhibited comparable PWT. Following THC or WIN treatment in male mice, SGIP1 knock-out males exhibited PWT lower than wild-type males. THC treatment in SGIP1 knock-out females resulted in PWT higher than after THC treatment of wild-type females. However, SGIP1 knock-out and wild-type female mice exhibited similar PWT after WIN treatment. Conclusions: We provide evidence that SGIP1, possibly by interacting with CB1R, is involved in processing the responses to chronic pain. The absence of SGIP1 results in enhanced sensitivity to mechanical stimuli in males, but not females. The antinociceptive effect of THC is superior to that of WIN in SGIP1 knock-out mice in the carrageenan-induced model of chronic pain.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009404
003      
CZ-PrNML
005      
20250429135535.0
007      
ta
008      
250415s2025 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1089/can.2024.0020 $2 doi
035    __
$a (PubMed)38979622
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Durydivka, Oleh $u Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000192064092
245    10
$a SGIP1 Deletion in Mice Attenuates Mechanical Hypersensitivity Elicited by Inflammation / $c O. Durydivka, M. Kuchar, J. Blahos
520    9_
$a Background: Activation of cannabinoid receptor 1 (CB1R) in the nervous system modulates the processing of acute and chronic pain. CB1R activity is regulated by desensitization and internalization. SH3-containing GRB2-like protein 3-interacting protein 1 (SGIP1) inhibits the internalization of CB1R. This causes increased and prolonged association of the desensitized receptor with G protein-coupled receptor kinase 3 (GRK3) and beta-arrestin on the cell membrane and results in decreased activation of extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. Genetic deletion of SGIP1 in mice leads to altered CB1R-related functions, such as decreased anxiety-like behaviors, modified cannabinoid tetrad behaviors, reduced acute nociception, and increased sensitivity to analgesics. In this work, we asked if deletion of SGIP1 affects chronic nociception and analgesic effect of Δ9-tetrahydrocannabinol (THC) and WIN 55,212-2 (WIN) in mice. Methods: We measured tactile responses of hind paws to increasing pressure in wild-type and SGIP1 knock-out mice. Inflammation in the paw was induced by local injection of carrageenan. To determine the mechanical sensitivity, the paw withdrawal threshold (PWT) was measured using an electronic von Frey instrument with the progression of the applied force. Results: The responses to mechanical stimuli varied depending on the sex, genotype, and treatment. SGIP1 knock-out male mice exhibited lower PWT than wild-type males. On the contrary, the female mice exhibited comparable PWT. Following THC or WIN treatment in male mice, SGIP1 knock-out males exhibited PWT lower than wild-type males. THC treatment in SGIP1 knock-out females resulted in PWT higher than after THC treatment of wild-type females. However, SGIP1 knock-out and wild-type female mice exhibited similar PWT after WIN treatment. Conclusions: We provide evidence that SGIP1, possibly by interacting with CB1R, is involved in processing the responses to chronic pain. The absence of SGIP1 results in enhanced sensitivity to mechanical stimuli in males, but not females. The antinociceptive effect of THC is superior to that of WIN in SGIP1 knock-out mice in the carrageenan-induced model of chronic pain.
650    _2
$a zvířata $7 D000818
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a zánět $7 D007249
650    _2
$a myši $7 D051379
650    12
$a tetrahydrokanabinol $x farmakologie $7 D013759
650    12
$a hyperalgezie $x genetika $7 D006930
650    12
$a benzoxaziny $x farmakologie $7 D048588
650    12
$a receptor kanabinoidní CB1 $x genetika $x metabolismus $7 D043884
650    12
$a myši knockoutované $7 D018345
650    _2
$a morfoliny $x farmakologie $7 D009025
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a nocicepce $x účinky léků $7 D059225
650    _2
$a naftaleny $7 D009281
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kuchar, Martin $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Forensic Laboratory of Biologically Active Substances, Prague, Czech Republic $u Psychedelic Research Center, National Institute of Mental Health, Klecany, Czech Republic $1 https://orcid.org/0000000276166352 $7 xx0070908
700    1_
$a Blahos, Jaroslav $u Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000198030061 $7 xx0179439
773    0_
$w MED00209151 $t Cannabis and cannabinoid research $x 2378-8763 $g Roč. 10, č. 2 (2025), s. 247-257
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38979622 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135530 $b ABA008
999    __
$a ok $b bmc $g 2311032 $s 1246485
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 10 $c 2 $d 247-257 $e 20240709 $i 2378-8763 $m Cannabis and cannabinoid research $n Cannabis Cannabinoid Res $x MED00209151
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...